Madrazo Delgado M, Uña Orejón R, Redondo Calvo F J, Criado Jiménez A
Servicio de Anestesia y Reanimación, Hospital General de Ciudad Real, Madrid.
Rev Esp Anestesiol Reanim. 2007 Aug-Sep;54(7):425-35.
Rhabdomyolysis is a clinical syndrome characterized by the breakdown and later necrosis of skeletal muscle, leading to the release of various intracellular components into the blood stream. The clinical expression of rhabdomyolysis ranges from asymptomatic to severe forms involving multiorgan failure with electrolyte imbalance, respiratory distress syndrome, acute renal failure and disseminated intravascular coagulation. Diagnosis is based on a finding of elevated serum levels of components that are normally found within the muscle cell, chiefly muscle enzymes and myoglobin. Acute kidney failure, one of the main consequences of rhabdomyolysis, occurs in 4% to 33% of cases. Treatment requires prompt volume replacement with crystalloids. In spite of successful resuscitation and prophylaxis against myoglobulin-induced renal failure, 1 out of every 3 patients develops kidney damage and requires continuous replacement therapy.
横纹肌溶解症是一种临床综合征,其特征是骨骼肌分解并随后坏死,导致各种细胞内成分释放到血流中。横纹肌溶解症的临床表现从无症状到严重形式不等,严重形式包括伴有电解质失衡、呼吸窘迫综合征、急性肾衰竭和弥散性血管内凝血的多器官功能衰竭。诊断基于发现血清中通常存在于肌肉细胞内的成分水平升高,主要是肌肉酶和肌红蛋白。急性肾衰竭是横纹肌溶解症的主要后果之一,发生率为4%至33%。治疗需要迅速用晶体液进行容量补充。尽管成功进行了复苏并预防了肌红蛋白诱导的肾衰竭,但每3名患者中仍有1人会发生肾损伤并需要持续替代治疗。